Observational Study of Glycaemic Control in Type 2 Diabetic Patients Uncontrolled on Oral Antidiabetic Agents and Starting With Once Daily Levemir (Insulin Detemir) - 24 Weeks, Prospective, Multicentre Observational Study in Hungary.
Phase of Trial: Phase III
Latest Information Update: 25 Nov 2016
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms HA-BOT
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 29 Jun 2012 Actual number of patients changed from 500 to 1032, as reported by ClinicalTrials.gov.
- 19 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.